FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4224001043> ?p ?o ?g. }

• W4224001043 endingPage "116" @default.
• W4224001043 startingPage "116" @default.
• W4224001043 abstract "I read with great interest the article by Miró et al., [[1]Miró Ò. Jiménez S. Llorens P. Roussel M. Gorlicki J. García-Lamberechts E.J. et al.Pulmonary embolism severity and in-hospital mortality: an international comparative study between COVID-19 and non-COVID patients.Eur J Intern Med. 2022; 98: 69-76https://www.ejinme.com/article/S0953-6205(22)00051-6/fulltextAbstract Full Text Full Text PDF PubMed Scopus (5) Google Scholar] as the paper discusses an important aspect of clinical medicine which is of great importance in the current coronavirus disease 2019 (COVID-19) era. It is questionable as to why the authors used simplified Pulmonary Embolism Severity Index (sPESI) scores while carrying out the risk analysis of both COVID-19 and non-COVID-19 patients, irrespective of the severity of the disease, for which the patients were previously diagnosed using a computed tomographic pulmonary angiogram (CTPA). The modified sPESI score (m-sPESI) proposed by As et al. could have proven to be of a more prognostic value for the COVID-19 patients and the regular sPESI score could have been used for the non-COVID-19 patients [[2]As A.K. Erdolu B. Duman B. Yazgan E. Eris C. Aydin U. et al.Can a modified-simplified pulmonary embolism severity index (m-sPESI) be used to predict the need for intensive care in hospitalized COVID-19 patients?.J Thromb Thrombolysis. 2021; 52: 759-765https://doi.org/10.1007/s11239-021-02405-7Crossref PubMed Scopus (3) Google Scholar]. Moreover, the study also had a higher proportion of elderly patients, with a median age of 67 years, and studies indicate that age is significantly associated with a fatal Pulmonary Embolism (PE) [[3]Muñoz-Torrero J.F.S. Bounameaux H. Pedrajas J.M. Lorenzo A. Rubio S. Kearon C. et al.Effects of age on the risk of dying from pulmonary embolism or bleeding during treatment of deep vein thrombosis.J Vasc Surg. 2011; 54: 26S-32Shttps://doi.org/10.1016/j.jvs.2011.05.114Abstract Full Text Full Text PDF PubMed Scopus (50) Google Scholar]. Furthermore, the study had 19.9% of non-COVID-19 patients having been diagnosed with a previous deep vein thrombosis (DVT), compared to only 6.4% of COVID-19 patients having been diagnosed with a previous DVT. Studies have indicated that there is a high risk of fatality from recurrent PE or DVT, and this could have potentially affected the study results [[4]Douketis J.D. Kearon C. Bates S. Duku E.K. Ginsberg J.S. Risk of fatal pulmonary embolism in patients with treated venous thromboembolism.JAMA. 1998; 279: 458-462https://doi.org/10.1001/jama.279.6.458Crossref PubMed Scopus (558) Google Scholar]. Another concerning aspect with respect to the list of risk factors for PE that was created for patients was that there is no classification indicating if patients had multiple risk factors, as multiple risk factors in a single patient could have led to there being a more possible chance for fatality from PE [[5]Laporte S. Mismetti P. Décousus H. Uresandi F. Otero R. Lobo J.L. et al.Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism: findings from the registro informatizado de la enfermedad tromboembolica venosa (RIETE) Registry: findings from the registro informatizado de la enfermedad tromboembolica venosa (RIETE) registry.Circulation. 2008; 117: 1711-1716https://doi.org/10.1161/CIRCULATIONAHA.107.726232Crossref PubMed Scopus (512) Google Scholar]. The absence of this classification fails to indicate the veracity of the findings as unfortunately if multiple COVID-19 patients were suffering from multiple risk factors, this could have been a possible reason for the higher mortality of COVID-19 patients as compared to non-COVID-19 patients. According to the original sPESI article by Jiménez et al., patients with an sPESI score of 0 were considered low risk and those with 1 or more were at high risk for PE [[6]Jiménez D. Aujesky D. Moores L. Gómez V. Lobo J.L. Uresandi F. et al.Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism.Arch Intern Med. 2010; 170: 1383-1389https://doi.org/10.1001/archinternmed.2010.199Crossref PubMed Scopus (776) Google Scholar]. Considering these facts, from the patient risk scoring, an analysis of the total percentages of risk scorings could have been done, but instead a stratified form of risk analysis was provided. Though both modalities are independently useful, a comparison of the two could have been more enlightening. Lastly, the main question is as to how the authors came to the end result. According to the article, there were 85 deaths, of which 56 were those of COVID-19 patients. In total, there were 747 subjects diagnosed with COVID-19 (439 were clinically diagnosed and 308 were PCR-confirmed). Hence, the total percentage of COVID-19 deaths related to PE would have been 7.49%, but the authors reported 12.8%, and it is not clear how they reached this conclusion. Again, in the case of non-COVID-19 deaths, there were 29 deaths among the 549 non-COVID-19 subjects, and this would have resulted in 5.28% of deaths, which the authors rounded off to 5.3%, which can be acceptable but the percentage provided for COVID-19 deaths related to PE cannot be validated. This discontinuity in reporting, with different results for the same formula for relative deaths is concerning. It would prove to be beneficial if the authors could correspondingly provide valid reasoning as to how they reached the 12.8% instead of the 7.49% fatality result." @default.
• W4224001043 created "2022-04-19" @default.
• W4224001043 creator A5055485694 @default.
• W4224001043 date "2022-07-01" @default.
• W4224001043 modified "2023-09-27" @default.
• W4224001043 title "Concerns regarding result analysis and the corresponding risk of pulmonary embolism severity and in-hospital mortality" @default.
• W4224001043 cites W1978280229 @default.
• W4224001043 cites W1999934104 @default.
• W4224001043 cites W2156917466 @default.
• W4224001043 cites W2166361233 @default.
• W4224001043 cites W3134011099 @default.
• W4224001043 cites W4210779476 @default.
• W4224001043 doi "https://doi.org/10.1016/j.ejim.2022.03.035" @default.
• W4224001043 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35382953" @default.
• W4224001043 hasPublicationYear "2022" @default.
• W4224001043 type Work @default.
• W4224001043 citedByCount "0" @default.
• W4224001043 crossrefType "journal-article" @default.
• W4224001043 hasAuthorship W4224001043A5055485694 @default.
• W4224001043 hasBestOaLocation W42240010431 @default.
• W4224001043 hasConcept C126322002 @default.
• W4224001043 hasConcept C17744445 @default.
• W4224001043 hasConcept C194828623 @default.
• W4224001043 hasConcept C199539241 @default.
• W4224001043 hasConcept C2776265017 @default.
• W4224001043 hasConcept C2779134260 @default.
• W4224001043 hasConcept C2779473830 @default.
• W4224001043 hasConcept C2779581417 @default.
• W4224001043 hasConcept C30036603 @default.
• W4224001043 hasConcept C3008058167 @default.
• W4224001043 hasConcept C500558357 @default.
• W4224001043 hasConcept C524204448 @default.
• W4224001043 hasConcept C71924100 @default.
• W4224001043 hasConcept C83867959 @default.
• W4224001043 hasConceptScore W4224001043C126322002 @default.
• W4224001043 hasConceptScore W4224001043C17744445 @default.
• W4224001043 hasConceptScore W4224001043C194828623 @default.
• W4224001043 hasConceptScore W4224001043C199539241 @default.
• W4224001043 hasConceptScore W4224001043C2776265017 @default.
• W4224001043 hasConceptScore W4224001043C2779134260 @default.
• W4224001043 hasConceptScore W4224001043C2779473830 @default.
• W4224001043 hasConceptScore W4224001043C2779581417 @default.
• W4224001043 hasConceptScore W4224001043C30036603 @default.
• W4224001043 hasConceptScore W4224001043C3008058167 @default.
• W4224001043 hasConceptScore W4224001043C500558357 @default.
• W4224001043 hasConceptScore W4224001043C524204448 @default.
• W4224001043 hasConceptScore W4224001043C71924100 @default.
• W4224001043 hasConceptScore W4224001043C83867959 @default.
• W4224001043 hasLocation W42240010431 @default.
• W4224001043 hasLocation W42240010432 @default.
• W4224001043 hasLocation W42240010433 @default.
• W4224001043 hasOpenAccess W4224001043 @default.
• W4224001043 hasPrimaryLocation W42240010431 @default.
• W4224001043 hasRelatedWork W1980538268 @default.
• W4224001043 hasRelatedWork W2098733091 @default.
• W4224001043 hasRelatedWork W2309437294 @default.
• W4224001043 hasRelatedWork W2347754406 @default.
• W4224001043 hasRelatedWork W2375104778 @default.
• W4224001043 hasRelatedWork W2714420706 @default.
• W4224001043 hasRelatedWork W2790618612 @default.
• W4224001043 hasRelatedWork W3032655376 @default.
• W4224001043 hasRelatedWork W4220879267 @default.
• W4224001043 hasRelatedWork W4288518460 @default.
• W4224001043 hasVolume "101" @default.
• W4224001043 isParatext "false" @default.
• W4224001043 isRetracted "false" @default.
• W4224001043 workType "article" @default.